Coronary artery disease (CAD) has a polygenic basis, and identification of CAD
susceptibility genes has the potential to aid the development of new treatments and …

Coronary artery disease (CAD) is still the number‐one killer in the world, and clinical trials
indicate that it is preventable. Mortality and morbidity can be reduced by at least 30% to 40 …

Coronary artery disease (CAD) is the leading cause of death and disability worldwide, and
its prevalence is expected to increase in the coming years. CAD events are caused by the …

Continuous updating of the genotyping technology has led to improvement of genetic study
design. The recent advances in technology coupled with the advances in our understanding …

Coronary artery disease (CAD) is the leading global cause of mortality.[1] Known risks to its
development are lifestyle choices, age, sex, and inherited genetic variants. An international …

As clinicians, we understand the development of atherosclerosis as a consequence of
cholesterol deposition and inflammation in the arterial wall, both being triggered by …

Coronary heart disease (CHD) is an archetypical multifactorial disorder that is influenced by
genetic susceptibility as well as both modifiable and nonmodifiable risk factors, and their …

We performed a meta-analysis of 14 genome-wide association studies of coronary artery
disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of …

An exciting new era has dawned for the prevention and management of coronary artery
disease (CAD) utilizing genetic risk variants. The recent identification of over 60 …

Abstract Purpose of Review We provide an overview of our current understanding of the
genetic architecture of coronary artery disease (CAD) and discuss areas of research that …